Clinical Trial Update: Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety study of autologous dendritic cells injected into the prostate after cryoablation in advanced prostate cancer was terminated, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Autologous dendritic cells

Snippet

Sponsor: Bostwick Laboratories | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2014-11-04